Gastric cancer

• Phase 1 First-In-Human Study to Explore the Safety, Tolerability, and Pharmacokinetics of AMG 305 in Subjects With Advanced Solid Tumors Ended
  2022-502867-39-00 1 2023-09-29 "Advanced solid tumors including non-small cell lung cancer ("
• A Phase 1 Study of SGN-ALPV in Advanced Solid Tumors Ended
  2022-500094-14-00 1 2022-11-08 "gastroesophageal junction [GEJ] carcinoma"
• A Phase 1a/1b Study Exploring the Safety and Tolerability of INCB081776 in Participants With Advanced Malignancies Ended
  2023-504400-29-00 1 2022-09-15 "Advanced malignancies."
• Bemarituzumab plus Chemotherapy and Nivolumab versus Chemotherapy and Nivolumab Alone (FORTITUDE-102) Ended
  2023-505458-16-00 5 2022-09-13 "Gastric and Gastroesophageal Junction Cancer With FGFR2b Ove"
• A Phase 1 open-label, first-in-human, multi-center, dose escalation and dose expansion study of CLN-619 administered alone or in combination … Ended
  2024-511744-27-00 1 2022-06-27 "Solid tumors, Non-Small Cell Lung Cancer, Cervical Cancer, E"
• Study Comparing Bemarituzumab plus Chemotherapy with Placebo and Chemotherapy in Previously Untreated Advanced Gastric or Gastroesophageal J … Ended
  2023-505457-40-00 5 2022-02-02 "Previously Untreated Advanced Gastric or Gastroesophageal Ju"
• A Phase 1b, Open-Label, Dose-Escalation Trial of the Safety of and Antigen-Specific Immune Responses Elicited by VB.10 NEO in Combination Wi … Ended
  2023-509996-18-00 1 2022-01-18 "Locally advanced and metastatic solid tumor including non-sm"
• Octreotide treatment to improve nutritional recovery after surgery for patients with esophageal or gastric cancer, a prospective randomized … Ended
  2022-502745-98-00 4 2020-11-17 "Esophageal and gastric cancer"
• A Phase 1b, Multicenter Study to Determine the Dose, Safety, Efficacy and Pharmacokinetics of TRK-950 when Used in Combinations with Selecte … Ended
  2024-513915-28-00 3 2019-06-14 "Bladder cancer, Cholangiocarcinoma, Colorectal Cancer, Epith"
• Safety Study of Anti-LAG-3 With and Without Anti-PD-1 in the Treatment of Solid Tumors Ended
  2023-508067-70-00 9 2015-04-15 "Neoplasms by site"
• CheckMate 032:CHECKpoint pathway and nivoluMAb clinical Trial Evaluation 032 Ended
  2024-516540-25-00 9 2013-12-11 "Advanced or metastatic solid tumors: 1) Triple Negative Brea"
• SPECT/CT imaging of FPI-2505 in patients with solid tumours; a phase 0 molecular imaging basket trial (SCOPE-study). Ended
  2025-521235-37-00 1 "small cell lung cancer, non-smallcell lung cancer, colorecta"

Showing 25–36 of 36 trials